Rupert Haynes

Corporate Officer/Principal bei RADIUS HEALTH, INC.

Health Technology

Profil

Rupert Haynes is currently the Head-Global Strategy at Radius Health, Inc. He was previously the Chief Executive Officer at FSD Pharma, Inc. from 2018 to 2019.
Prior to that, he held positions as Director-Global Marketing at GW Pharmaceuticals Ltd.
and Head-Global Commercial Operations at Swedish Orphan Biovitrum AB.

Aktive Positionen von Rupert Haynes

Unternehmen	Position	Beginn
RADIUS HEALTH, INC.	Corporate Officer/Principal	01.02.2021

Alle aktiven Positionen von Rupert Haynes

Ehemalige bekannte Positionen von Rupert Haynes

Unternehmen	Position	Ende
FSD PHARMA INC.	Chief Executive Officer	06.02.2019
GW PHARMACEUTICALS PLC	Sales & Marketing	-
SWEDISH ORPHAN BIOVITRUM AB	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Rupert Haynes im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Rupert Haynes im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	2
SWEDISH ORPHAN BIOVITRUM AB	Health Technology
FSD PHARMA INC.	Health Technology

Private Unternehmen	2
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology
GW Pharmaceuticals Ltd. GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.	Health Technology